在单一纤维瘤中,NAB2-STAT6驱动了一个依赖EGR1的神经内分泌程序
Connor M Hill1,2, Alexandra Indeglia1,3, Francis Picone1
1The Wistar Institute, Philadelphia, PA, US.
bioRxiv : the preprint server for biology
|April 25, 2024
概括
孤独纤维性瘤 (SFTs) 涉及NAB2-STAT6基因融合,通过改变基因表达来驱动瘤生长. 这一发现为这些罕见的癌症揭示了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 孤独纤维性瘤 (SFTs) 是一种罕见的介质细胞瘤,通常被误诊为软组织瘤.
- 虽然手术是标准的,但30-40%的SFT复发或转移,突显了有效的全身治疗的必要性.
- NAB2-STAT6基因融合是SFTs的分子标志,但其在病原发生中的功能作用尚不清楚.
研究的目的:
- 阐明由NAB2-STAT6融合蛋白驱动的SFT病原体的分子机制.
- 确定由NAB2-STAT6.6规范的特定的转录目标和细胞功能.
- 探索基于已识别的分子通路的潜在治疗策略.
主要方法:
- 使用初级SFT样本和可诱导细胞模型来研究NAB2-STAT6功能.
- 研究了NAB2-STAT6与转录因子的相互作用,特别是EGR1.
- 分析基因表达特征,专注于核局部化和转录协激活.
- 研究了STAT6部分在核转位和协同激活能力中的作用.
主要成果:
- NAB2-STAT6作为转录协激活剂,劫持EGR1向的增强剂和促进剂.
- 融合蛋白促进NAB1,NAB2和EGR1的核定位,增强神经元EGR1标的表达.
- STAT6组件对于核定位和增强的协同激活至关重要.
- 在初级瘤中,NAB2-STAT6激活了独特的神经内分泌基因特征,使SFT与其他瘤区别开来.
结论:
- NAB2-STAT6作为一种强大的转录协活性剂,通过改变基因表达驱动SFT病原体.
- 融合蛋白激活神经内分泌基因签名的能力为SFT分类提供了分子基础.
- 这些发现为SFT生物学提供了新的见解,并确定了恶性SFT的潜在治疗点.
更多相关视频
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.9K
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
559
相关概念视频
02:55The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K